News

BostonSight wants to redefine ocular surface treatment

BostonSight wants to redefine ocular surface treatment

In February, BostonSight announced a transformative 5-year strategic roadmap aimed at redefining ocular surface treatment through groundbreaking advancements in clinical research, education, and specialty lens technology. The organization has designated key leadership roles to lead initiatives that accelerate innovation and collaboration, with the goal of positively impacting patient lives around the world. Dr. Karen Carrasquillo,…

Alcon reports 7% CL sales uptick in Q4

Alcon reports 7% CL sales uptick in Q4

Alcon reported $683 million in contact lens sales for Q4 2025, a 7 percent year-on-year increase driven by new product launches and price increases, particularly in North America. Price resistance was stronger elsewhere: “If you look at the European market, you have got a lot of big chains who basically are telling us they are…

Specialty Contact Lens Travel Grants by Art Optical

Specialty Contact Lens Travel Grants by Art Optical

Art Optical Contact Lens, Inc., a provider of custom contact lenses, in partnership with Contamac, a manufacturer of contact and intraocular lens materials, recently named the winners of their Specialty Contact Lens Travel Grants. According to the announcement, these individuals have demonstrated the use of Art Optical lens designs to solve patient needs in unique…

Menicon ends Rose K manufacturing partnership with Blanchard Contact Lenses

Menicon ends Rose K manufacturing partnership with Blanchard Contact Lenses

Menicon Co., Ltd, a global contact lens manufacturer, announced that it has concluded its Rose K manufacturing partnership with Blanchard Contact Lenses, a division of CooperVision, effective December 31, 2025. Blanchard had been an important and valued Rose K partner since 2003, the company said, contributing more than two decades of expertise to the fitting,…

LENZ Therapeutics reports preliminary Q4 2025 results

LENZ Therapeutics reports preliminary Q4 2025 results

LENZ Therapeutics, Inc., a pharmaceutical company focused on the commercialization of VIZZ (aceclidine ophthalmic solution) 1.44%, has announced certain preliminary unaudited financial results for the fourth quarter ended December 31, 2025 and recent corporate updates. Approved by the FDA in August 2025, VIZZ is a once-daily aceclidine-based eye drop for the treatment of age-related presbyopia….

CLI names 2025 Culture Award Honorees

CLI names 2025 Culture Award Honorees

The Contact Lens Institute (CLI) has announced the winners of its 2025 Contact Lens Institute Culture Awards, recognizing five U.S. and Canadian eyecare teams and individuals. These honorees were selected for their successful efforts in cultivating contact lens cultures that lead to improved patient experiences and better business outcomes, the group advised. According to the…

The Eye Consortium adds Bausch + Lomb as partner

The Eye Consortium adds Bausch + Lomb as partner

The Eye Consortium (TEC), an alliance group for independent practices, has formed a new Elite Vendor partnership with Bausch + Lomb to help advance TEC’s ongoing commitment to deliver programs and resources that help the alliance’s member doctors elevate both the patient experience and practice profitability. “In response to the overwhelming interest from our membership,…

Prevent Blindness names Matt MacDonald as Chair of Board of Directors

Prevent Blindness names Matt MacDonald as Chair of Board of Directors

Prevent Blindness, has announced that Matt MacDonald, president and global head of managed care, EyeMed Vision Care, was appointed chair of its board of directors on November 14, at the 2025 Prevent Blindness annual board meeting here. MacDonald succeeds Jim McGrann, CEO of Advancing Eyecare, who was named an emeritus member of the board. At…

Custom contact lens manufacturer Scotlens unveils new brand identity

Custom contact lens manufacturer Scotlens unveils new brand identity

Scotlens, a leading custom contact lens manufacturer, has unveiled its refreshed brand identity at the Hospital and Specialty Optometrists Conference (8–9 November 2025). The rebrand follows its acquisition by Contact Lens Precision Laboratories (CLPL) six months ago and aligns Scotlens with CLPL and sister company Ultravision, which rebranded in 2024. “This integration strengthens our mission…

ONE by ONE Recycling program collects used contact lens

ONE by ONE Recycling program collects used contact lens

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company, has announced its ONE by ONE Recycling program has collected a total of 691,180 pounds, or 114,037,136 units, of used contact lens, eyecare and lens care materials in the United States. The program, created in collaboration with international recycling leader TerraCycle, continues to…